Rasmussen LK, Johnsen LB, Tsiora A, Sorensen ES, Thomsen, JK, Nielsen NC, et al. Disulphide-linked caseins and micelles. Int Dairy J 1999;6(3):215-8.
DOI: 10.1016/S0958-6946(99)00063-1
Cossais F, Clawin-Rädecker I, Lorenzen PC, Klempt M. Tryptic β-casein hydrolysate modulates enteric nervous system development in primary culture (short communication). J Dairy Sci 2017;100(5):3396-403.
DOI: 10.3168/jds.2016-11440
Jonker J, Wijngaarden M, Kloek J, Groeneveld Y, Gerhardt C, Brand R, et al. Effects of low doses of casein hydrolysate on post-challenge glucose and insulin levels. Eur J Int Med 2011;22(3):245-8.
DOI: 10.1016/j.ejim.2010.12.015
Daly A, Evans S, Chahal S, Santra S, MacDonald A. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control? J Hum Nutr Diet 2017;30:515-23.
DOI: 10.1111/jhn.12438
López-Bajonero LJ, Iara-Calderon P, Gálvez-Mariscal A, Velásquez-Arellano A, López-Munguia A. Enzymatic production of a low-phenylalanine product from skim powder and caseinate. J Food Sci 1991;56(4):938-42.
DOI: 10.1111/j.1365-2621.1991.tb14610.x
Fisberg RM, Silva-Femandes ME, Fisberg M, Schmidt BJ. Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria. Nutrition 1999;15(6):449-52.
DOI: 10.1016/S0899-9007(99)00082-9
Ahring K, Quintana AB, Dokoupil K, Ozel HG, Lammardo AM, Mac Donald A, et al. Dietary management practices in phenylketonuria across European centres. Clin Nutr 2009;28(3):231-6.
DOI: 10.1016/j.clnu.2009.03.004
Ahring K, Quintana AB, Dokoupil K, Ozel HG, Lammardo AM, Mac Donald A, et al. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres. Eur J Clin Nutr 2010;65(2):275-8.
DOI: 10.1038/ejcn.2010.258
Rijn MV, Hoeksma M, Sauer P, Szczerbak B, Gross M, Reijngoud DJ, et al. Protein metabolism in adult patients with phenylketonuria. Nutrition 2007;23(6):445-53.
DOI: 10.1016/j.nut.2007.03.009
MacLeod EL, Clayton MK, Calcar SCV, Ney DM. Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria. Mol Genet Metab 2012;100(4):303-8.
DOI: 10.1016/j.ymgme.2010.04.003
Association of Official Analytical Chemists International. Official methods of analysis of AOAC International. 15th ed. Arlington; 1990.
Alsmeyer RH, Cunningham AE, Happich ML. Equations predict PER from amino acid analysis. Food Technol 1974;28:34-8.
Gaucheron F, Graet YL, Boyaval E, Piot M. Binding of cations to casein molecules: importance of physicochemical conditions. Milchwissenschaft 1997;52:322-7.
Pérès JM, Bouhallab S, BureauF, Neuville D, Maubois JL, Devroede G, et al. Mechanisms of absorption of caseinophosphopeptide bound iron. J Nutr Biochem 1999;10(4):215-22.
DOI: 10.1016/S0955-2863(98)00101-6
Reynolds EC. Production of phosphopeptide from casein. United States Patent nº US 6448374. 2002.
Kitts DD, Yuan YV, Nagasawa T, Moryama Y. Effects of casein, casein phosphopeptide and calcium intake on ileal 45Ca disappearance and temporal systolic blood pressure in spontaneously hypertensive rats. Br J Nutr 1992;68(3):765-81.
DOI: 10.1079/BJN19920132
Sato R, Shindo M, Gunshin H, Noguchi T, Naito H. Characterization of phosphopeptide derived from β-casein: an inhibitor to intra-intestinal precipitation of calcium phosphate. Biochim Biophys Acta 1991;1077(3):413-5.
DOI: 10.1016/0167-4838(91)90559-I
Al-Qadreh A, SchulpisKH, Athanasopoulou H, Mengreli C, Skarpalezou A, Zoskaki I. Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr 1998;87(11):1162-6.
DOI: 10.1111/j.1651-2227.1998.tb00924.x
20. Groot MJ, Hoeksma M, Rijn MV, Slart RJA, Spronsen FJV. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients. Mol Genet Metab 2012;105(4):566-70.
DOI: 10.1016/j.ymgme.2012.01.006
Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 2007;30:202-8.
DOI: 10.1007/s10545-007-0462-9
Bernardi CR, Luiz MTB, Zanotto DL, Guidoni AL. Preparo de hidrolisados proteicos para a análise de aminoácidos. Ciênc Tecnol Aliment 2003;23(3):317-22.
DOI: 10.1590/S0101-20612003000300004
Food and Agriculture Organization (FAO); World Health Organization (WHO). Evaluation on protein and amino acid requirements in human nutrition. Report of the joint FAO/WHO/ONU. Expert consultation on protein and amino acid requirement in human nutrition. United Nation University. WHO Technical Report Series n° 935. Geneva; 2007.
Monteiro LTB. Desenvolvimento de uma formulação proteica com teor reduzido de fenilalanina [Dissertation]. Curitiba: Federal University of Paraná; 2003.
Lammardo AM, Robert M, Rocha JC, Van Rijn M, Ahring K, Bélanger-Quintana A, et al. Main issues in micronutrients supplementation in phenylketonuria. Mol Genet Metab 2013;110:1-5.
DOI: 10.1016/j.ymgme.2013.08.008
Ayalew Y, Retta N, Desse G, Mohammed A, Mellesse A. Amino acid profile and protein quality in tuber and leaf of Coccnia abyssinica (Lam.) (Cogn.) accessions of Ethiopia. Food Sci Nutr 2017;5:722-9.
DOI: 10.1002/fsn3.452
Hernández-Ledesma B, García-Nebot MJ, Fernández-Tomé S, Amigo L, Recio I. Dairy protein hydrolysates: peptides for health benefits. Int Dairy J 2014;38(02):82-100.
DOI: 10.1016/j.idairyj.2013.11.004
Strisciuglio P, Concolino D. New strategies for the treatment of phenylketonuria (PKU). Metabolites 2014;4(4):1007-17.
DOI: 10.3390/metabo4041007
Ney DM, Gleason ST, Calcar SCV, MacLeod EL, Nelson KL, Etzel MR, et al. Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis 2009;32(1):32-9.
DOI: 10.1007/s10545-008-0952-4
Van Calcar SC, Macleod EL, Gleason ST, Etzel MR, Clayton MK, Wolff JA, et al. Improved nutritional management phenylketonuria by using a diet containing glycomacropeptide compared with amino acids. Am J Clin Nutr 2009;89:1068-77.
DOI: 10.3945/ajcn.2008.27280